コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 3,646.18, or 51.7%, annually by adopting the new technology.
2 saved by the laboratory by converting to the new technology.
3 t existing storage ring sources by utilizing new technology.
4 the potential diagnostic advantages of this new technology.
5 RNA-Seq data and improve inference from this new technology.
6 the adoption and long-term sustainability of new technology.
7 gest no unanticipated risks inherent to this new technology.
8 usly anticipated through the introduction of new technology.
9 pting to regulate genome editing itself as a new technology.
10 e management strategies, including promising new technologies.
11 B/RIF, there is now considerable interest in new technologies.
12 ign rules and accelerates the translation of new technologies.
13 t the expanded dynamic range afforded by the new technologies.
14 y 1990s opened the door to a wide variety of new technologies.
15 and patient selection, as well as evaluating new technologies.
16 llows, offering perspectives for a number of new technologies.
17 ety of measurements made to date using these new technologies.
18 regulations are only slowly adapting to the new technologies.
19 health, and social impacts while developing new technologies.
20 we review some of the major lessons of these new technologies.
21 safety and trends for these rapidly evolving new technologies.
22 n translational research are often driven by new technologies.
23 ds, integrate innovative programs, and adopt new technologies.
24 uate the dynamic performance of existing and new technologies against climate-change mitigation goals
25 fate reprogramming concepts have jumpstarted new technologies aimed at the functional regeneration of
28 several years have witnessed an explosion of new technologies, allowing us to apply even more of the
35 ns, and many of their questions have yielded new technologies and areas of investigation, thus remain
37 S that thwarted past efforts, and armed with new technologies and directions, the field is experienci
39 n of epidemiology studies using the evolving new technologies and genetics (host susceptibility studi
40 ally designed to allow easy incorporation of new technologies and image formats as they are developed
43 together with research outcomes arising from new technologies and methodologies will inform novel str
45 and discuss potential applications of these new technologies and of the analyses of the increasing v
48 f field-scale experimentation when assessing new technologies and production-system performance, espe
50 nventions that will be compatible with these new technologies and support the data representation nee
51 entifying more than 400 cases through use of new technologies and surveillance tools made possible by
53 research is explosive and when combined with new technologies and techniques provides the potential f
54 ith the current availability of reagents and new technologies and the exchange of concepts and data a
56 l platform for clinical application of these new technologies and to provide guidance to clinicians o
63 ion, describe recent advances resulting from new technologies, and synthesize these findings into an
65 through their interactions with their host; new technologies are beginning to reveal important aspec
71 The field stands at an exciting point where new technologies are making long-standing questions amen
73 vanillin and other marketable products, but new technologies are needed to enhance the lignin value
76 An increasing number of applications of the new technologies are providing broad insights into bacte
81 f health-service delivery, and adaptation of new technologies, are needed to address neglected and em
82 are ready to be explored for applications in new technology areas, such as electronics, biomedical de
85 ght into biological mechanisms and providing new technologies based on dynamic physical properties.
88 and make recommendations on the use of this new technology based on both published evidence and expe
90 in this field is very promising with several new technologies being applied to the analysis of the co
91 onetheless, we detail how the integration of new technology, biological understanding, epidemiology a
96 ocrystals promise exciting opportunities for new technologies, but basic features of the relationship
97 vascular scaffolds (BVS) represent promising new technology, but data on their long-term outcomes in
99 f metabolic engineering and will discuss how new technologies can enable metabolic engineering to be
101 e we illustrate how historical knowledge and new technologies can reveal the potential of nonconventi
104 agriculture, where behavioral practices and new technologies could contribute significantly to reduc
105 onmental costs and benefits of introducing a new technology depend not only on the technology itself,
108 -mediated cyclization has become a promising new technology due to its efficiency, safety, and cost-e
109 ronmental diagnostics, better molluscicides, new technologies (e.g., gene drive), and 'outside the bo
111 of materials that can be studied expands as new technologies evolve and are applied in innovative wa
114 us on precision medicine, and application of new technologies for delivering support in real time and
116 are considered by researchers when designing new technologies for developing countries, the basic asp
117 tility of MOFs materials in order to develop new technologies for environmental remediation purposes.
118 approach including conventional methods and new technologies for evaluation of cell lines for unexpe
119 clinical decision making and in implementing new technologies for genetic analysis into clinical prac
121 e-scale sequencing continues to decrease and new technologies for genome editing become widely adopte
125 oned over the past decade with the advent of new technologies for interrogating complex microbial com
126 e availability of large-scale sequencing and new technologies for investigating gene function, many n
127 ological and biochemical data, together with new technologies for manipulating microbial genomes, all
131 ild on existing technologies and to generate new technologies for the diagnosis of a broad spectrum o
133 t single-base resolution in DNA could enable new technologies for understanding carcinogenesis and su
135 We apply our approach in a case study on a new technology for chlor-alkali electrolysis to be intro
139 site-specific nucleases provides a powerful new technology for gene modification to potentially mode
140 SLE patients thus supporting the use of this new technology for in-depth single gene transcript profi
142 g have enabled the development of a powerful new technology for probing the adaptive immune system.
144 nues to be tremendous interest in developing new technology for sensitive protein detection that is b
146 udies set the stage for exploitation of this new technology for the analysis of S. pombe proteins.
149 e demonstrated the potential utility of this new technology for vaccine development with the identifi
150 tering a collaborative era in which powerful new technologies, generated by large scientific projects
155 pture the contact structure in wild animals, new technology has enabled biologists to obtain detailed
163 d related 2D materials has recently led to a new technology: heterostructures based on these atomical
169 ging cancer therapies and rapid diffusion of new technologies in the absence to evidence indicating i
171 receive the necessary education to use this new technology in the most effective, beneficial manner.
174 tus is mostly made with ultrasound; however, new technologies, including 3- and 4-dimensional echocar
176 re tests, and extended automation as well as new technologies, including mass spectrometry for colony
177 e leadership and coordination in integrating new technologies into routine practice throughout the U.
180 es) has the potential for incorporating this new technology into neural stimulation prosthetics, such
183 functional characterization of cancer, this new technology is evolving significantly more slowly tha
185 All Markers of Hypothyroidism" should read "new technology is needed to allow for steady delivery of
188 A number of recent papers have exploited new technologies, like single molecule tracking and real
191 the late 1960s may help us understand how a new technology makes its way into routine clinical pract
192 of future sequencing platforms and how these new technologies may improve on current sequencing platf
196 s, focusing on what is still unknown and how new technologies might be used to understand what change
198 tonic circuits promises to catalyse powerful new technologies much like electronic circuits have in t
199 g portion of the human genome as well as the new technologies necessary to apply this knowledge to JI
200 etics, including the development of powerful new technologies, new data from genetic research on chil
202 clinical experiences, and implementation of new technology, nutrition educators have an opportunity
203 s innovative information on the influence of new technologies of ageing (stainless steel tanks with w
204 novel experimental strategies including the new technology of massively parallel sequencing has prov
206 he effects on the introduction or receipt of new technologies on study outcomes during a 2-year follo
210 have been developed because of the advent of new technologies, particularly cell culture and molecula
211 rstanding natural phenomenon and engineering new technologies, particularly in systems with molecular
213 em has long been recognized, new science and new technologies promise exciting prospects for the futu
214 ecific Cre-loxP-mediated recombination, this new technology provides more precise analysis of cell li
215 ssing implementation gaps, and ensuring that new technologies reach those who need them to survive.
218 ogrammatic efficiency, exploring the role of new technologies, rethinking demand creation, strengthen
219 chnologies that remain competitive after the new technology's introduction determine the new environm
220 CT in diseased eyes will further define this new technology's utility in chorioretinal diseases.
222 microbe interactions has largely been due to new technologies such as 16S rRNA sequencing to identify
224 ormance computing, thin films, or completely new technologies such as flexible and transparent device
225 function should inspire more work harnessing new technologies such as imaging, proteomics, and gene e
229 th the promise of advanced architectures and new technologies, such as microfabricated ion traps and
232 Based on the same knowledge but thanks to new technologies, such hospitals have now been built dow
233 " of cancer epidemiology research, including new technologies, team science multilevel research, and
236 e in bacteria, and hence there is a need for new technologies that can quantify antibiotic transport
237 the development, study and implementation of new technologies that circumvent insecticide resistance.
238 imple geometries, and end by discussing both new technologies that could drive further discovery and
239 We also describe unsolved mysteries and new technologies that could help to overcome experimenta
241 ess in directed differentiation, some of the new technologies that have facilitated the success of hP
242 ultiple existing preservation approaches and new technologies that have flourished in the past 10 yea
245 ing a few nucleosomes, but thanks in part to new technologies that permit targeted alteration of chro
246 xciting times for hemophilia because several new technologies that promise extended half-lives for fa
249 phy with enhanced depth imaging (OCT-EDI), a new technology that allows visualization of structures p
250 de that microneedle patches offer a powerful new technology that can enable more effective vaccinatio
252 ization of exonic splicing mutations using a new technology that facilitates variant classification a
256 gital polymerase chain reaction (ddPCR) is a new technology that was recently commercialized to enabl
257 tal control strategies (i.e., investments in new technology), the potential of operational control st
258 rmination using 2 conventional methods and 2 new technologies: the Haigis-L formula, Masket regressio
261 uture research, including the development of new technologies to access and quantify the full spectru
262 ganic gases is a critical step in developing new technologies to allow manufacturing to occur in a mo
263 s research directions that take advantage of new technologies to build a quantitative and mechanistic
264 rly characterized, underscoring the need for new technologies to characterize MTs and their inhibitor
265 ssembly quality, suggesting the necessity of new technologies to comprehensively map ethnic and perso
266 hods to select more accurate lens power, and new technologies to confirm proper axis alignment have a
267 ovided by DNA/RNA nanotechnology and related new technologies to construct nucleic acid nanostructure
268 on increasing coverage and incorporation of new technologies to enhance current cervical screening a
269 ults anticipate the need and use of emerging new technologies to establish models that will accommoda
271 Evolving concepts regarding pathogenesis and new technologies to evaluate the tears and ocular surfac
272 g-resistant pathogens and the development of new technologies to find and produce such compounds have
275 nses of sugarcane impairs the development of new technologies to increase sugarcane drought tolerance
277 e review the potential applications of these new technologies to the study of tumor biology and discu
279 cation of agents (metabolomics, proteomics), new technology to evaluate both physical and social envi
280 Ca(2+) transporters in crops is a promising new technology to improve dietary Ca supplies through bi
281 in high-resolution optical screening offer a new technology to more rapidly evaluate antimicrobial su
291 rarely resist opportunities to capitalize on new technologies when they opened some interesting part
292 al role in successful implementation of this new technology, whereby a small, narrow protein crystal
293 REE that are critical for the development of new technologies, which now overwhelm natural REE anomal
294 rch and the development and dissemination of new technologies will eventually necessitate an update o
297 d RNA, and are facilitating a broad range of new technologies with chemical, biological and biomedica
299 The review presents and discusses these new technologies within the context of directed evolutio
300 ular access is a critical challenge for this new technology, yet even the most basic aspect of this p
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。